WHO ICTRP trial
Comparison between 5 days of radiotherapy followed by chemotherapy with 25 days…
CTRI/2023/10/058369 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2023/10/058369 |
|---|---|
| Public title | Comparison between 5 days of radiotherapy followed by chemotherapy with 25 days of radiotherapy with daily oral chemotherapy in locally advance rectal cancer |
| Scientific title | Comparison of Overall Response to Neoadjuvant Short Course Radiotherapy Followed by Consolidation Chemotherapy with Long Course Chemoradiotherapy in Locally Advanced Rectal Cancer - Nil |
| Primary sponsor | AIl India institute of medical sciences New Delhi |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2/ Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: C20- Malignant neoplasm of rectum |
| Interventions | Intervention1: Short course radiotherapy followed by consolidation chemotherapy: Radiation-Total 25 Gy is delivered in 5 fractions of 5Gy each over 1 week. Neoadjuvant chemotherapy -chemotherapy will be started within 7 to 10 days of… |
| Registration date | May 10, 2023 |
| Target size | 60 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: